Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR3 | P22607 | 16/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17023070 | 0.95 | FGFR3 (0.59) | FGFR3KDM4EGAAMEN1HSP90AA1 | |
| SCHEMBL17023038 | 0.91 | FGFR3 (0.55) | FGFR3 | |
| SCHEMBL17023021 | 0.91 | FGFR3 (0.57) | FGFR3KDM4EGAAMEN1HSP90AA1 | |
| SCHEMBL1127004 | 0.88 | FGFR3 (0.73) | FGFR3 | |
| SCHEMBL17023079 | 0.86 | FGFR3 (0.58) | FGFR3 | |
| SCHEMBL17023124 | 0.84 | FGFR3 (0.51) | FGFR3 | |
| SCHEMBL1126549 | 0.83 | FGFR3 (0.75) | FGFR3 | |
| SCHEMBL17023030 | 0.83 | FGFR3 (0.48) | FGFR3 | |
| SCHEMBL17023064 | 0.81 | FGFR3 (0.47) | FGFR3 | |
| SCHEMBL17023165 | 0.81 | FGFR3 (0.55) | FGFR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2282995-B1 | DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 2015-08-26 | — | — | EP | claimed |